The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q-New prognostic markers are needed
|
Dec 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
|
Feb 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Good riddance to the term "refractory anemia" in myelodysplastic syndromes
|
Oct 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Molecular genetics in myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia
|
Jun 2018
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Question prompt list responds to information needs of myelodysplastic syndromes patients and caregivers
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
New therapeutics for myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)
|
Nov 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Myelodysplastic syndromes: Aiming at deciphering their secrets
|
Oct 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|